Bio-Techne Corp TECH +3.64% increased by 4% following news that Ananym Capital Management has acquired a significant stake in the company. The activist investor is advocating for a strategic review, including a potential sale, arguing that this approach would maximize shareholder value compared to remaining independent. Ananym expressed concern over the company's past performance, highlighting a need for immediate action to avoid further value loss. Currently, Bio-Techne has a market capitalization of $8.45 billion and has seen its stock decline by 8.2% over the last year
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.